Targeting c-myc in leukemia

Anti-Cancer Drug Design

Volumn 12, Issue 5, 1997, Pages 373-381

  Calabretta, Bruno ^a   Skorski, Tomasz ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BCR ABL PROTEIN; MYC PROTEIN; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; BURKITT LYMPHOMA; CHRONIC MYELOID LEUKEMIA; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; LEUKEMIA; MELANOMA; MOUSE; NONHUMAN; ONCOGENE C MYC; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, MYC; HUMANS; LEUKEMIA; OLIGONUCLEOTIDES, ANTISENSE;

ANIMALIA;

EID: 0030812288     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. ADAMS, J.H., HARRIS, A.W. & PURKITT, C.A (1985). The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature, 318, 533.
2. AFAR, D.E.H., GOGA, A., MCLAUGHLIN, J., WITTE, O.N. & SAWYERS, C.L. (1994). Differential complementation of Bcr-Abl point mutants with c-Myc. Science, 264, 424.
3. AGRAWAL, S., TERNSAMANI, T. & TANG, JY. (1991). Pharmacokinetics, biodistribution and stability of oligodeoxynucleotide phosphorothioates in mice. Proceedings of the National Academy of Sciences of the USA, 88, 7595.
4. ARMELIN, H.A., ARMELIN, M.C.S., KELLY, K., STEWART, T., LEDER, P., COCHRAN, B H. & STILES, C.D. (1984). Functional role for c-myc in mitogenic response to platelet derived growth factor. Nature, 310, 655.
5. BURGESS, T.L., FISHER, E.F., ROSS, S.L., BREADY, J.V., QUIAN, Y.-X., BAYEWITCH, L.A., COHEN, A.M., HENERA, C.J., H U, S.-F., KRAMER, T.B., LOTT, F.O., MARTIN, F.H., PIERCE, G.F, SIMONET, L. & FANEL, C.L. (1995). The antiproliferative activity of c-myb and c-myc antisense oligodeoxynucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proceedings of the National Academy of Sciences of the USA, 92, 4051.
6. COLLINS, S. & GROUDINE, M. (1982). Amplification of endogenous myc-related DNA sequences in a human myeloid leukemia cell line. Nature (London), 299, 679.
7. COLLINS, S.J., RUSCETTI, F.W., GALLAGHER, R.E. & GALLO, R.C. (1978). Terminal differentiation of human promyelocytic leukemia cells induced by dimethylsulfoxide and other polar compounds. Proceedings of the National Academy of Sciences of the USA, 75, 2458.
8. bcr/abl gene of the Philadelphia chromosome. Science, 247, 824.
9. DALLA-FAVERA, R., WONG-STAAL, F. & GALLO, R.C (1982). one gene amplification in promyelocytic leukemia cell line HL-60 and primary leukemic cells of the same patient. Nature, 299, 61.
10. DALLA-FAVERA, R., MARTINOTTI, S., GALLO, R.C., ERICKSON, J. & CROCE, C.M. (1983). Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B cell lymphomas. Science, 219, 963.
11. EPNER, D.E. & KOEFFLER, H.P. (1990). Molecular genetic advances in chronic myelogenous leukemia. Annals of Internal Medicine, 113, 3.
12. 1 Natur, 328, 445.
13. HEISTERKAMP, N., JENSTER, G, TEN HOEVE, J., ZOVICH, D., PATTENGALE, P.K. & GROFFEN, J. (1990). Acute leukemia in bcrlabl transgenic mice. Nature, 344, 251.
14. HOLT, J.T., REDNER, R.L. &. NIENHUIS, A.W. (1988). An oligomer complementary to c-myc messenger RNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Molecular and Cellular Biology, 8, 963.
15. HUANG, Y., SNYDER, R., KLIGSHTEYN, M. & WICKSTROM, E (1995). Prevention of tumor formation in a mouse model of Burkitt's lymphoma by 6 weeks of treatment with anti-c-myc DNA phosphorothioate. Molecular Medicine, 1, 647.
16. KACZMAREK, L , HYLAND, J.K., WATT, R., ROSENBERG, M. & BASERGA, R. (1985). Microinjected c-myc as a competence factor. Science, 228, 1313.
17. KAMEL-REID, S., LETARTE, M., SIRARD, C., DOEDENS. M , GRUNBERGER, T., FIELDS, C., FREEDMAN, M.H., PHILLIPS, R.A & DICK, J.E. (1989). A model of human acute lymphoblastic leukemia in immunodeficient SCID mice. Science, 246, 1597.
18. KANTARJAN, H.M , DEISSEROTH, A., KURZROCK, R., ESTROV, Z. & TALPAZ, M. (1993). Chronic myelogenous leukemia: a concise update. Blood, 82, 91.
19. KELLY K., COCHRAN, B H, STILES, C.D. & LEDER, P (1983). Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell, 35, 603.
20. LEONETTI, C., D'AGNANO, I., LOZUPONE, F , VALENTINI, A., GEISER, T., ZON. G., CALABRETTA, B., CITRO, G. & ZUPI, G. (1996). Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and in mice. Journal of the National Cancer Institute, 88, 419.
21. SAWYERS, C L., CALLAHAN, W. & WITTE, ON. (1992). Dominant negative MYC blocks transformation by ABL oncogenes. Cell, 70, 901.
22. SAWYERS, C.L., MCLAUGHLIN, J. & WITTE, O.N. (1995). Genetic requirement for RAS in the transformation of fibroblasts and hematopoietic cells by the BCR/ABL oncogene, Journal of Experimental Medicine, 181, 307.
23. SKORSKI, T., NIEBOROWSKA-SKORSKA, M., BARLETTA, M , MALAGUARNERA, L., SZCZYLIK, C , CHEN, S.-T., LANGE, B. & CALABRETTA, B. (1993). Highly efficient elimination of Philadelphia' leukemic cells by exposure to bcrlabl antisense oligodeoxynucleotides combined with mafosfamide. Journal of Clinical Investigation, 92, 194.
24. SKORSKI, T., NIEBOROWSKA-SKORSKA, M., CAMPBELL, K., IOZZO, R V., ZON, G., DARZYNKIEWICZ, Z. & CALABRETTA, B. (1995). Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes. Journal of Experimental Medicine, 182, 1645.
25. SKORSKI, T., NIEBOROWSKA-SKORSKA, M., WLODARSKI, P., ZON, G., IOZZO, R.V. & CALABRETTA, B. (1996). Antisense oligodeoxynucleotide combination therapy of primary chronic myelogenous leukemic blast crisis in SCID mice. Blood, 88, 1005.
26. 1 phosphoramidate antisense oligonucleotides in vivo. Proceedings of the National Academy of Sciences of the USA, in press.
27. SZCZYLIK, C., SKORSKI, T., NICOLAIDES, N.C., MANZELLA, L., MALAGUARNERA, L., VENTURELLI, D., GEWIRTZ, A.M. & CALABRETTA, B. (1991). Selective inhibition of leukemia cell proliferation by bcr-abl antisense oligodeoxynucleotides. Science, 253, 562.
28. TAUB, R., KIRSCH, I., MORTON, C., LENOIR, G., SWAN, D., TRONICK, S., AARONSON, S. & LEDER, P. (1982). Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proceedings of the National Academy of Sciences of the USA, 79, 7837.
29. WICKSTROM, E L., BACON, T.A., GONZALES, A., FREEMAN, D.L., LYMAN, G.H. & WICKSTROM, E. (1988). Human promyelocytic leukemia HL-60 cell proliferation and c-myb protein expression are inhibited by an antisense pentadecadeoxy-nucleotide targeted against c-myc mRNA. Proceedings of the National Academy of Sciences of the USA, 85, 1028.
30. YASWEN, P., STAMPFER, M.R., GHOSH, K. & COHEN, J S. (1993). Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells. Antisense Research Development, 3, 67.
31. ZHAO, Q , SONG, X., WALDSCHMIDT, T., FISHER, E. & KRIEG. A.M (1996). Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation. Blood, 88, 1788.